Clinical Trial

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Recruiting
View on ClinicalTrials.gov →
Summary
The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.
Protocol Amendment History 38 amendments
This ClinicalTrials.gov record has been amended 38 times since 2020-06-09; most recent amendment 2026-07-21.
Status change: Not Yet Recruiting → Recruiting 2021-01-19
Trial Details
NCT Number NCT04427384
Lead Sponsor GT Medical Technologies, Inc.
Conditions Brain Tumor, Recurrent, Brain Tumor, Brain Tumor, Primary, Brain Tumor - Metastatic, Brain Tumor, Adult: Glioblastoma, Brain Tumor, Adult Meningioma
Enrollment 600 participants
Start Date 2020-09-11
Primary Completion 2028-10-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-22